Drug Profile
Research programme: herpes simplex virus inhibitors - ICOS
Alternative Names: IC 977467Latest Information Update: 13 Jul 2006
Price :
$50
*
At a glance
- Originator ICOS Corporation
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 13 Jul 2006 Discontinued - Preclinical for Herpes simplex virus infections in USA (unspecified route)
- 01 Jun 2004 Preclinical trials in Herpes simplex virus infections in USA (unspecified route)